Rhythm Pharmaceuticals, Inc. announced today the results from a proof-of-concept, Phase 1b clinical trial assessing the safety and efficacy of setmelanotide (RM-493), the company's novel...

Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the presentation of clinical data featuring the use of its Precision Cancer MonitoringSM (PCM) platform...

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced that top-line renal results from the EMPA-REG OUTCOME® study (compound empagliflozin,...

Functional Neuromodulation Ltd. announced that an analysis of the ADvance Study, a Phase 2 double-blind randomized controlled trial of DBSf for mild Alzheimer's disease (clinicaltrials.gov...

CareFusion, a BD company (NYSE:BDX), will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association...